View Older Stories View More Recent Stories

Mar 29, 2016 12:21PM Form 4 Corvus Pharmaceuticals, For: Mar 29 Filed by: ORBIMED ADVISORS LLC
Mar 17, 2016 11:57AM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Mar 16, 2016 03:30PM Form SC 13D/A Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 16, 2016 07:45AM New Rational Combinations for Immuno-Oncology Conference Announced for NYC Addressing Novel Trial Designs and Business Development Strategies
Feb 16, 2016 04:31PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 16, 2016 03:48PM Form SC 13G/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 02:07PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:37PM Form SC 13G/A SYNERGY PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:34PM Form SC 13G IMMUNOMEDICS INC Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:31PM Form SC 13G eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:28PM Form SC 13G DYNAVAX TECHNOLOGIES Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:27PM Form SC 13G ProNAi Therapeutics Inc Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:23PM Form SC 13G/A COGENTIX MEDICAL INC Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:18PM Form SC 13G/A Biodel Inc Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 08:11AM Unilife Corp. (UNIS), Amgen (AMGN) Extend Exclusivity Period; Unilife Announces Amendment to Credit Agreement
Feb 16, 2016 06:24AM Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 06:20AM Form SC 13G/A Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:17PM Form SC 13G/A IMPAX LABORATORIES INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:15PM Form SC 13G Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:12PM Form SC 13G INSMED Inc Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:09PM Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:06PM Form SC 13G IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:42PM Form SC 13G CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:40PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:37PM Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:34PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:29PM Form SC 13G/A ARQULE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:26PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:23PM Form SC 13G ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:14PM Form SC 13G GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 05:09PM Form SC 13G/A XENOPORT INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:55PM Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:52PM Form SC 13G/A SINOVAC BIOTECH LTD Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:50PM Form SC 13G/A Sientra, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:44PM Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:42PM Form SC 13G PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:39PM Form SC 13G Ophthotech Corp. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:37PM Form SC 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:35PM Form SC 13G/A NEUROCRINE BIOSCIENCES Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G MAGELLAN HEALTH INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G/A Mirati Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:29PM Form SC 13G/A MEI Pharma, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:28PM Form SC 13G/A MOLINA HEALTHCARE INC Filed by: ORBIMED ADVISORS LLC
Jan 11, 2016 08:00AM Adimab Provides Update on Recent Partnerships and Milestones
Jan 6, 2016 06:00AM NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Dec 24, 2015 08:43AM OrbiMed Advisors Sells Nearly 500K Shares of RELYPSA (RLYP); Still Has Significant 17.75% Stake
Dec 24, 2015 08:36AM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Dec 23, 2015 05:06PM Form 4 Relypsa Inc For: Dec 21 Filed by: ORBIMED ADVISORS LLC
Dec 16, 2015 01:01AM Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
Dec 14, 2015 06:00AM Viralytics Completes $28 million Placement -- SPP to Follow
View More Recent Stories View Older Stories